ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AIKI Alkido Pharma Inc

3.56
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Alkido Pharma Inc NASDAQ:AIKI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.56 3.53 3.98 0 01:00:00

Spherix Announces Filing of its Annual Report on Form 10-K, Records $7.5 Million One Time Gain

12/03/2019 12:00pm

PR Newswire (US)


Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Alkido Pharma Charts.

NEW YORK, March 12, 2019 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX)- a technology development company committed to the fostering of innovative ideas, announced today that it has filed its Annual Report on Form 10-K for the year ended December 31, 2018 with the Securities and Exchange Commission.

Spherix Logo. (PRNewsFoto/Spherix Incorporated)

A copy of the Annual Report on Form 10-K is available to be viewed or downloaded from the Investor Relations Section of the Company's Website, here. Financial highlights include a $7.5 million one time gain for the quarter, total assets of $13.3 million, approximately 8 million shares currently outstanding and no debt. Hard copies of the Annual Report on Form 10-K are being mailed to shareholders in advance of the Annual Meeting on April 15, 2019.

"2018 proved to be a pivotal year in the growth and development of the Company. During the fourth quarter that ended December 31, 2018, we recorded a $7.5 million one-time gain due in large part to the successful integration of our recent investments," stated Anthony Hayes, CEO of Spherix.

"Going forward, we will continue to examine similar accretive acquisitions," added Hayes.

About Spherix Incorporated

Spherix Incorporated is a technology development company committed to the fostering of innovative ideas. Spherix Incorporated was formed in 1967 as a scientific research company. Our activities generally include the acquisition and development of technology through internal or external research and development. In addition, we seek to acquire existing rights to intellectual property through the acquisition of already issued patents and pending patent applications, both in the United States and abroad. We may alone, or in conjunction with others, develop products and processes associated with technology development and monetizing related intellectual property.

Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the SEC, not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact:


Investor Relations:

Hayden IR


Brett Maas, Managing Partner


Phone: (646) 536-7331


Email: brett@haydenir.com


www.haydenir.com



Spherix:

Phone: 212-745-1373


Email: investorrelations@spherix.com


www.spherix.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/spherix-announces-filing-of-its-annual-report-on-form-10-k-records-7-5-million-one-time-gain-300810550.html

SOURCE Spherix Incorporated

Copyright 2019 PR Newswire

1 Year Alkido Pharma Chart

1 Year Alkido Pharma Chart

1 Month Alkido Pharma Chart

1 Month Alkido Pharma Chart

Your Recent History

Delayed Upgrade Clock